BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fu M, Yu J, Chen Z, Tang Y, Dong R, Yang Y, Luo J, Hu S, Tu L, Xu X. Epoxyeicosatrienoic acids improve glucose homeostasis by preventing NF-κB-mediated transcription of SGLT2 in renal tubular epithelial cells. Mol Cell Endocrinol 2021;523:111149. [PMID: 33387601 DOI: 10.1016/j.mce.2020.111149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Guan XX, Rao DN, Liu YZ, Zhou Y, Yang HH. Epoxyeicosatrienoic Acids and Fibrosis: Recent Insights for the Novel Therapeutic Strategies. Int J Mol Sci 2021;22:10714. [PMID: 34639055 DOI: 10.3390/ijms221910714] [Reference Citation Analysis]
2 Shi Z, He Z, Wang DW. CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators. Molecules 2022;27:3873. [PMID: 35744996 DOI: 10.3390/molecules27123873] [Reference Citation Analysis]
3 Luo J, Hu S, Fu M, Luo L, Li Y, Li W, Cai Y, Dong R, Yang Y, Tu L, Xu X. Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney. J Biol Chem 2021;296:100667. [PMID: 33864813 DOI: 10.1016/j.jbc.2021.100667] [Reference Citation Analysis]